Immunocore Holdings Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -145.0% | – | – | – | – | – | – | – | – | +1,020.1% | -130.6% | |
| – | +90.2% | +104.5% | +49.6% | +61.5% | +37.4% | -2.6% | -15.4% | -29.7% | -39.3% | +29.9% | -42.2% | |
| – | +2,170.7% | +14.0% | +94.1% | -79.6% | +358.9% | +167.1% | +499.0% | -32.7% | -21.9% | +33.1% | +10.3% | |
| – | – | – | – | – | – | +871.1% | +36.0% | -51.3% | – | – | – | |
| – | – | – | – | – | -114.9% | – | – | – | – | +886.3% | -115.3% | |
| – | +185.5% | +6.7% | +186.8% | -80.0% | +20.9% | -28.1% | -54.9% | +58.9% | +94.9% | +20.5% | -37.6% | |
| – | -8.5% | – | -133.1% | – | -107.1% | – | -374.1% | +71.6% | +95.4% | +8,172.1% | -96.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | -121.8% | +0.0% | – | -109.5% | +1.6% | -100.0% | – | -100.0% | |
| – | +39,115.7% | -99.9% | +20,040.5% | -99.5% | +54,481.2% | +110.3% | +148.6% | -49.5% | -81.3% | +1,165.2% | -97.3% | |
| – | – | – | -138.8% | – | -221.5% | – | +159.1% | -43.6% | -61.0% | -58.8% | -32.2% | |
| – | -162.8% | – | – | – | – | – | – | – | – | – | -153.6% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.